336 related articles for article (PubMed ID: 7328566)
1. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
Shingu M; Todoroki T; Sakai K; Nobunaga M
J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
[TBL] [Abstract][Full Text] [Related]
2. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
Sølling J; Sølling K; Jacobsen KU
Acta Derm Venereol; 1979; 59(5):421-6. PubMed ID: 93365
[TBL] [Abstract][Full Text] [Related]
4. Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).
Hurst NP; Nuki G; Wallington T
Clin Exp Immunol; 1984 Feb; 55(2):303-12. PubMed ID: 6697566
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
6. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
8. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Miyamoto T
J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
[TBL] [Abstract][Full Text] [Related]
9. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
10. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
Ho A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
[TBL] [Abstract][Full Text] [Related]
11. Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. A corollary of disease activity.
Scheinberg MA; Israel Filho G; Mendes NF; Vertzman L
J Rheumatol; 1978; 5(1):19-25. PubMed ID: 305960
[TBL] [Abstract][Full Text] [Related]
12. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
Valentijn RM; van Es LA; Daha MR
J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
[TBL] [Abstract][Full Text] [Related]
13. Decreased circulating thymus-derived cells with receptors for the Fc portion of immunoglobulin G in systemic lupus erythematosus.
Alarcón-Segovia D; Ruíz-Argüelles A
J Clin Invest; 1978 Dec; 62(6):1390-4. PubMed ID: 311785
[TBL] [Abstract][Full Text] [Related]
14. Reticuloendothelial system Fc receptor function in systemic lupus erythematosus.
Kabbash L; Brandwein S; Esdaile J; Danoff D; Fuks A; Shuster J
J Rheumatol; 1982; 9(3):374-9. PubMed ID: 7120232
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
[TBL] [Abstract][Full Text] [Related]
16. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
[TBL] [Abstract][Full Text] [Related]
17. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of complement dependent active adherence on SLE and RA leukocytes.
Dénes L; Falus A; Böhm U; Merétey K
Acta Physiol Acad Sci Hung; 1981; 58(1):21-9. PubMed ID: 7342695
[TBL] [Abstract][Full Text] [Related]
19. Studies on human blood lymphocytes with iC3b (type 3) complement receptors. I. Granular, Fc-IgG receptor positive and negative subsets in healthy subjects and patients with systemic lupus erythematosus.
Bakke AC; Gray JD; Abo W; Quismorio FP; Lash A; Cooper SM; Horwitz DA
J Immunol; 1986 Feb; 136(4):1253-9. PubMed ID: 2935574
[TBL] [Abstract][Full Text] [Related]
20. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
Wager O
Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
[No Abstract] [Full Text] [Related]
[Next] [New Search]